DigestRedComo funciona
Red
/
Empresas
En
No verificado

Encoded Therapeutics, Inc.

Sobre qué escribimos

BiotecnologíaFarmacéuticaIndustriaMedicina - VariosSalud

6 Comunicados de prensa

Ver todos los comunicados de prensa
08/09/2026
Ferias y Congresos
Eventos
Industria
Ciencia
Biotecnología
Farmacéutica
Sanidad
Salud
Medicina - Varios
Encoded Therapeutics Presents Updated Data from POLARIS Phase 1/2 Trials of ETX101 Gene Therapy in Dravet Syndrome at the 16th European Epilepsy Congress
Fuente
Encoded Therapeutics, Inc.
Editor
Business Wire
1.00
0
13/05/2026
Industria
Salud
Biotecnología
Medicina - Varios
Farmacéutica
Encoded Therapeutics Presents New Clinical Data from POLARIS Phase 1/2 Trials of ETX101 Gene Therapy in Dravet Syndrome at the ASGCT 2026 Presidential Symposium
Fuente
Encoded Therapeutics, Inc.
Editor
Business Wire
1.00
0
06/05/2026
Industria
Ciencia
Biotecnología
Farmacéutica
Salud
Higiene alimentaria
Medicina - Varios
Encoded Therapeutics Doses First Patient in Pivotal Study of ETX101 for Dravet Syndrome and Reports Broader Portfolio Progress
Fuente
Encoded Therapeutics, Inc.
Editor
Business Wire
1.00
0
27/04/2026
Eventos
Industria
Biotecnología
Salud
Farmacéutica
Medicina - Varios
Encoded Therapeutics to Present ETX101 Data in Dravet Syndrome at the 2026 ASGCT Presidential Symposium
Fuente
Encoded Therapeutics, Inc.
Editor
Business Wire
1.00
0
25/03/2026
Industria
Salud
Biotecnología
Medicina - Varios
Farmacéutica
Encoded Therapeutics Announces FDA Alignment, Initiation of Pivotal Study, and ASGCT Presidential Symposium Presentation of ETX101 in Dravet Syndrome
Fuente
Encoded Therapeutics, Inc.
Editor
Business Wire
1.00
0
12/01/2026
Higiene alimentaria
Salud
Biotecnología
Farmacéutica
Industria
Encoded Therapeutics Announces U.S. FDA Breakthrough Therapy Designation Granted to ETX101 for the Treatment of Dravet Syndrome
Fuente
Encoded Therapeutics, Inc.
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0